This company introduces its improved micro-particle enhanced (MPE) C-reactive protein (CRP) assay for its Array 360 protein system.
The CRP assay is for the quantitative determination of CRP in human serum and plasma. The assay replaces the Array 360 system’s former CRP test, which will be phased out over the next 12 months.
The assay improves the sensitivity of the serology panel on Array 360 systems. It features a dynamic range of 0.1 to 54 mg/dL, can detect lower concentration levels of CRP than its predecessor and reduces possible interference from triglyceride, billirubin and hemoglobin.
Beckman Coulter
www.CLPmag.com
Keywords: CRP, infection
